Home › GSK hopes big clinical trial can breathe new life into lung drug
 

Keywords :   


GSK hopes big clinical trial can breathe new life into lung drug

2015-08-13 20:06:52| Biotech - Topix.net

GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result. Data from the so-called SUMMIT study, designed to show GSK's Breo can prolong lives of patients with chronic lung disease, are expected as early as next month, nine years after a similar study with GSK's older drug Advair failed by a whisker.

Tags: life big trial drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.04This Week in Agribusiness, April 20, 2024
20.04This Week in Agribusiness, April 20, 2024
20.04App to cut EU border queues won't be ready in time
19.04PPG Board of Directors Announce Quarterly Dividend of 65 Cents Per Share
19.04Can AI help solve Japans labour shortages?
19.04 PPG Board of Directors Authorizes $2.5 Billion Share Repurchase Program
19.04Warning jailed bankers ruling could hit loan rate
19.04NFU Statement on EPA E15 Announcement
More »